SOURCE: Elsevier Business Intelligence

Elsevier Business Intelligence

October 23, 2009 10:11 ET

Device Valuations Remain Very Attractive to VCs and Business-Development Execs at Elsevier Business Intelligence's 'IN3 Medical Device Summit'

More Than 250 Attendees, 25 Sponsors and 50 Presenting Companies Convened in San Francisco This Week

SAN FRANCISCO, CA--(Marketwire - October 23, 2009) - Elsevier Business Intelligence, the medtech industry's leading strategic partner and investment conference organizer, hosted the year's largest annual strategic partnership and investment meeting, 'IN3 Medical Device Summit', on October 20-21 at San Francisco's InterContinental Mark Hopkins Hotel. This event followed Elsevier Business Intelligence's 'Medical Device Investor Day', also held at the InterContinental Mark Hopkins, on October 19.

IN3 Medical Device Summit, with 25 sponsors, was attended by more than 250 registered guests, including venture capitalists and medtech business-development executives who learned about the latest innovations and investment opportunities from 50 emerging medical technology companies seeking funding and/or strategic partnerships.

"This conference offered me the chance to sit down not only with a major multinational company but also several other investors whom I would not likely have met otherwise," said Allen Braswell, President and CEO of Pico-Tesla Magnetic Therapies, one of the presenting companies at the IN3 Medical Device Summit. "This is my second IN3 event, and I believe these meetings offer emerging companies a great value for getting in front of top-shelf investors."

"The IN3 Medical Device Summit proved to be a very effective venue for us to heighten awareness about our organization," added Mark B. Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), one of the sponsors of IN3 Medical Device Summit.

Upcoming IN3 events include: (1) March 3-5, 2010, IN3 WEST, Las Vegas: "Growing Your Medical Technology Business through Financing, M&A and Strategic Partnerships" (The Venetian Resort Hotel & Casino); and (2) April 29-30, 2010: IN3 EUROPE, Paris: "Bridging European and U.S. Medical Device Innovators, Investors and Companies" (Marriott Rive Gauche Hotel). For more information about these upcoming IN3 conferences, visit or contact Kristy Grimes at 480-985-9512, 888-290-2225 (U.S. toll-free), or email

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as Science Direct (, MDConsult (, Nursing Consult (, Scopus (, bibliographic databases, and online reference works.

Elsevier ( is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (, a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Contact Information

  • Contact:
    Ronald Trahan, APR
    Ronald Trahan Associates Inc.
    508-359-4005, x108